英夫利昔单抗的疗效 ,Abatacept,和 Cenicriviroc 用于治疗住院的 COVID - 19 肺炎成人。
关键词: COVID-19 Clinical status Clinical trial Hospitalized patients Immunomodulators Totality of evidence
Mesh : Humans Abatacept / therapeutic use Infliximab / therapeutic use Double-Blind Method Male Middle Aged Female COVID-19 Drug Treatment COVID-19 Treatment Outcome SARS-CoV-2 Aged Hospitalization Adult Immunomodulating Agents / therapeutic use
来 源:
DOI:10.1016/j.ijid.2024.107168
PDF(Pubmed)